The DOI matches its Crossref record; 167 of the 171 references it cites were found in a registry or an index.
The PI3K/AKT pathway in obesity and type 2 diabetes
Open accessAbstract
Obesity and type 2 diabetes mellitus are complicated metabolic diseases that affect multiple organs and are characterized by hyperglycaemia. Currently, stable and effective treatments for obesity and type 2 diabetes mellitus are not available. Therefore, the mechanisms leading to obesity and diabetes and more effective ways to treat obesity and diabetes should be identified. Based on accumulated evidences, the PI3K/AKT signalling pathway is required for normal metabolism due to its characteristics, and its imbalance leads to the development of obesity and type 2 diabetes mellitus. This review focuses on the role of PI3K/AKT signalling in the skeletal muscle, adipose tissue, liver, brain and pancreas, and discusses how this signalling pathway affects the development of the aforementioned diseases. We also summarize evidences for recently identified therapeutic targets of the PI3K/AKT pathway as treatments for obesity and type 2 diabetes mellitus. PI3K/AKT pathway damaged in various tissues of the body leads to obesity and type 2 diabetes as the result of insulin resistance, and in turn, insulin resistance exacerbates the PI3K/AKT pathway, forming a vicious circle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AKT activation leads to increased glucose transporter 4 (GLUT4) expression and translocation, ultimately leading to increased glucose uptake.”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“PI3K is an enzyme that activates protein kinase B (AKT), which regulates glucose metabolism, among other intracellular functions [48].”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 1×
“AKT-mediated mTORC1 activation regulates a number of downstream effectors proteins through phosphorylation, including the well-characterized effectors p70 ribosomal S6 protein kinase-1 (S6K1) and eukaryotic translation initiation factor-4E (eIF4E)binding protein-1 (4E-BP1), to increase protein synthesis [43, 44].”
BackgroundPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 1×
“AKT regulates two processes by glycolysis Glucose 6-phosphate and glycogen synthase kinase 3 (GSK3) to produce cellular energy via glycolysis and promotes glycogen production by inhibiting [30].”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“In obese subjects, excess levels of circulating FFAs, which are caused by a blunted response of adipose tissues, impairs the function of β cells [150].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 8×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialAKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772 · cited 2×
“Similar phosphorylation events are observed at corresponding residues in AKT2 (T309 and S474) and AKT3 (T305 and S472) [22].”
BackgroundRole of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117 · cited 1×
“In the presence of persistent excess energy availability, leptin signalling activates other pathways, such as STAT3 or SH2-containing tyrosine phosphatase, to predominantly regulate food intake in POMC neurons [90, 113, 119].”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 1×
“Chronic metabolic inflammation and endoplasmic reticulum (ER) stress also impair hepatic insulin-AKT signalling and subsequently causes insulin resistance [106, 107].”
BackgroundHealth and economic burden of the projected obesity trends in the USA and the UK
Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., & Brown, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60814-3 · Cited by 2,775 · cited 1×
“The prevalence of obesity has grown at an alarming rate although specific public health policies and treatment efforts have been developed to resist the obesity epidemic [1], potentially leading to increased numbers of patients affected by complications of obesity, such as the most devastating type 2 diabetes mellitus…”
Background
Flagged first, then by citations
4 of the 171 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- [98]Yecies Jessica L Zhang Hui H Menon S Liu S Yecies D Lipovsky Alex I Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways Cell metabolism 2011 14 1 21 32 21723501 PMC3652544
- [120]Al-Qassab H Smith MA Irvine EE Guillermet-Guibert J Claret M Choudhury AI Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons Cell metabolism 2009 10 5 343 54 19883613 PMC2806524
- [144]Bernal-Mizrachi E Wen W Stahlhut S Welling CM Permutt MA Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia J Clin Invest 2001 108 11 1631 8 11733558 PMC200992
- [147]Wang HW Mizuta M Saitoh Y Noma K Ueno H Nakazato M Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic beta-cells Metabolism 2011 60 8 1081 9 21255808
- [161]Villani V Milanesi A Sedrakyan S Da Sacco S Angelow S Conconi MT Amniotic fluid stem cells prevent beta-cell injury Cytotherapy 2014 16 1 41 55 24210784 PMC4374982
Cited by
Sorted by citations
Items 301–400 of 1,008
Wang, K., Kong, L., Wen, X., Li, M., Su, S., Ni, Y., & Gu, J. (2023) · Nutrients · doi:10.3390/nu15040824 · Cited by 14
“The liver is a crucial organ for keeping bodily glucose homeostasis [32].”
BackgroundGanekal, P., Vastrad, B. M., Kavatagimath, S., Vastrad, C. M., & Kotrashetti, S. (2023) · Medicina · doi:10.3390/medicina59020309 · Cited by 22
“Recent investigations showed that PI3K/AKT pathway [10] and TLR pathway [11] as a potential target for diabetes mellitus and obesity.”
BackgroundLu, M., Wang, Y., Jiang, Y., Zhang, C., Wang, H., Sha, W., Chen, L., Lei, T., & Liu, L. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04604-z · Cited by 13
“The phosphorylated AKT1 further simulates glycogen synthesis by augmenting the level of glycogen synthase [15].”
BackgroundComparative Study of Two Common In Vitro Models for the Pancreatic Islet with MIN6
Chao, X., Zhao, F.-R., Hu, J.-W., Yu, Y.-R., Xie, R.-J., Zhong, J.-N., Huang, M., Zeng, T., Yang, H., Luo, D., et al. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00507-8 · Cited by 12
Wang, Q., Li, N., Wang, Y., Li, R., Jia, Y., Zhou, J.-N., Liu, J., Zhang, M., Zhuang, P.-W., He, C.-W., et al. (2022) · Journal of Ethnopharmacology · doi:10.2139/ssrn.4229804 · Cited by 12
Cao, Y., Wang, J., Wei, F., Gu, Q., Tian, M., & Lv, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175297 · Cited by 12
Zhang, J., Cao, W., Zhao, H.-A., Guo, S., Wang, Q., Cheng, N., & Bai, N.-S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.925351 · Cited by 12
“The phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway regulates metabolism in normal physiology and morbid conditions, and diseases such as obesity and diabetes are related to it (12).”
BackgroundLiang, M., Li, Y., Ai, Y., & Ji, R. (2025) · Food Chemistry: X · doi:10.1016/j.fochx.2025.102729 · Cited by 11
“The PI3K-AKT signaling pathway, which plays a pivotal role in insulin stimulation and cell survival (Huang et al., 2018), is participated in metabolic diseases such as diabetes.”
Wang, X., Bakar, M. H. A., Kassim, M. A., Shariff, K., & Rosdi, M. N. M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.101928 · Cited by 11
Zhao, Z., Wu, W.-G., Zhang, Q., Xing, T., Bai, Y., Li, S., Zhang, D., Che, H., & Guo, X. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117817 · Cited by 11
Wen, Y., Mei, L., Dan Yang, Zeng, Y., Zhao, C.-X., Wang, Y.-Z., & Wang, J.-G. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08118 · Cited by 11
The hypoglycemic activity of buckwheat and the underlying mechanisms: A mechanistic review
Jin, X., He, C., Guo, Z., Li, Y., Li, Y., Gao, J., Wang, M., & Han, L. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105046 · Cited by 13
Dietary modulation of microRNAs in insulin resistance and type 2 diabetes
Capetini, V. C., Quintanilha, B. J., Garcia, B. R. E. V., & Rogero, M. M. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109714 · Cited by 13
Majo, D. D., Ricciardi, N., Liberto, V. D., Allegra, M., Frinchi, M., Urone, G., Scordino, M., Massaro, A., Mudò, G., Ferraro, G., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117028 · Cited by 11
Niu, W., Feng, Y.-S., Peng, M., & Cai, J.-Y. (2024) · Phytotherapy Research · doi:10.1002/ptr.8276 · Cited by 11
“The Akt family is downstream of PI3K in the insulin signaling pathway, of which Akt2 is the most expressed in insulin-sensitive tissues (Huang et al., 2018).”
Azizan, Z., Zali, H., Mirmotalebisohi, S. A., Bazrgar, M., & Ahmadiani, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304410 · Cited by 11
“Studies have shown that the ECM, through OPN/SPP1 binding integrins and CD44, can activate focal adhesion signaling [24, 34, 35] and PI3K/Akt pathways [21, 36, 37], which are involved in inflammation, glucose metabolism, and the buildup of amyloid plaques.”
BackgroundSelectivity Studies and Free Energy Calculations of AKT Inhibitors
Zhong, H. A., & Goodwin, D. T. (2024) · Molecules · doi:10.3390/molecules29061233 · Cited by 16
“Dysregulation, mutations, and malfunction of this pathway can induce various types of cancer, such as B cell malignancies, breast cancer, and renal cell carcinoma [1–3], and diabetes [4].”
BackgroundChapple, B. E., Woodfin, S., & Moore, W. (2024) · Molecules · doi:10.3390/molecules29040751 · Cited by 14
“In the β -cell, the activation of the PI3K/Akt pathway leads to insulin secretion, and a failure to activate PI3K/Akt signaling in the β -cell blocks insulin secretion [27,28].”
BackgroundExploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis
Li, Y., Zhang, L., Du, Q., Gong, X., & Tian, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-46795-5 · Cited by 16
“An increasing number of evidence has demonstrated that PI3K/Akt pathway played a crucial role in T2D, and it could be a promising therapeutic target for the treatment of T2D 49–51 .”
BackgroundLipidomic landscape of lipokines in adipose tissue derived extracellular vesicles
Zhang, Y., Dong, T., & Wang, M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1281244 · Cited by 14
“The PI3K/AKT signaling pathway promotes lipid biosynthesis and inhibits lipolysis in adipose tissue and liver (Li et al., 2011; Huang et al., 2018).”
BackgroundGestational diabetes mellitus: genetic factors, epigenetic alterations, and microbial composition
Lizárraga, D., Gómez‐Gil, B., García-Gasca, T., Ávalos-Soriano, A., Casarini, L., Salazar-Oroz, A., & García-Gasca, A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02176-y · Cited by 27
“The authors identified differentially expressed miRNAs in these exosomes, which are involved in mitogen-activated protein kinase signalling related with obesity and DM2 [147].”
Wang, J.-Y., Yang, H., Wang, C., & Kan, C. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02110-2 · Cited by 11
“The PI3K/Akt is a main insulin pathway, and its imbalance contributes to the development of type 2 diabetes mellitus [31].”
BackgroundAlhamoud, Y., Wu, J., Ahmad, M. I., Chen, F., Feng, F., & Wang, J. (2023) · Food Frontiers · doi:10.1002/fft2.251 · Cited by 12
Hasanian-Langroudi, F., Ghasemi, A., Hedayati, M., Siadat, S. D., & Tohidi, M. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10056-8 · Cited by 11
“…which mediates growth factor signals that are pivotal to organismal growth and various cellular events, such as glucose metabolism, lipid metabolism, and protein synthesis; thus, manipulation of the PI3K/AKT pathway and its downstream mediators is a favorable target for the management of T2DM [20].”
Khandelwal, M., Krishna, G., Ying, Z., & Gómez‐Pinilla, F. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166728 · Cited by 14
Zhang, X., Sun, M., Li, D., Miao, X., Mei, H., Sun, R., Su, Y., Chi, Y., Wang, J., & Niu, H. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/5876706 · Cited by 10
Advanced Glycation End Products Effects on Adipocyte Niche Stiffness and Cell Signaling
Izgilov, R., Naftaly, A., & Benayahu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032261 · Cited by 11
“This affected membrane dynamics and also altered insulin signaling, as measured by a decrease in protein kinase B (AKT) phosphorylation, which mediates insulin signaling, and this results in insulin resistance (IR), as in type 2 diabetes (T2D) [16,17].”
BackgroundAlfheeaid, H., Alhowail, A., Ahmed, F., Zaki, A., & Alkhaldy, A. (2023) · Brain Science · doi:10.3390/brainsci13020165 · Cited by 11
“Insulin binds to insulin receptors to activate the PI3K/Akt signaling pathway [40], which plays a vital role in glucose transporter 4 (GLUT4) traveling to the cell surface that ultimately reduces hyperglycemia [41].”
BackgroundMao, X., Zhou, J.-L., Kong, L.-M., Zhu, L., Yang, D.-S., & Zhang, Z. (2023) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2023.01.004 · Cited by 11
Li, X., Zhang, H., Wang, Y., Li, Y.-Y., Wang, Y.-L., Zhu, J.-J., & Lin, Y.-Q. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012295 · Cited by 11
“In adipocytes, the PI3K/Akt signaling pathway promotes lipid biosynthesis and inhibits lipid hydrolysis and is a positive regulator of adipocyte differentiation [55].”
BackgroundPark, J.-E., & Han, J.-S. (2022) · Nutrients · doi:10.3390/nu14183815 · Cited by 16
Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance
Ma, X., Ru, Y., Luo, Y., Kuai, L., Chen, Q., Bai, Y. C., Liu, Y., Chen, J., Luo, Y. Y., Song, J., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.942838 · Cited by 14
Non-Diabetic Hypoglycemia: Evaluation and Management in Adults
Looi, E., & Lawler, H. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134393 · Cited by 10
“PI3K is an enzyme that activates protein kinase B (AKT), which regulates glucose metabolism, among other intracellular functions [48].”
Interactions between serum uric acid and gut microbiota: implications for metabolic health
Ali, N. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100438 · Cited by 11
“As discussed above, T2D and IR, increased SUA worsens the impairment of glucose uptake by inhibiting the PI3K/AKT pathway, while changes in the microbiome also add to lipotoxicity and alter bile acid signaling [59,60].”
He, F., Su, S., Song, R., Li, Y., Zou, L., Li, Z., Xiao, Y., Hou, A.-X., Li, K., & Wang, Y.-L. (2025) · Antioxidants · doi:10.3390/antiox14091065 · Cited by 10
“…inflammatory damage and insulin resistance [50]; (2) functional restoration of the PI3K-Akt pathway, a hub for insulin signal transduction, directly ameliorates glucose metabolism disorders [51]; (3) modulation of the HIF-1 pathway may mitigate diabetes-associated hypoxic stress [52].”
Wang, Z.-X., Ma, T.-Y., Bai, G., Fang, Q., Ou, B.-Q., Chen, M., Xu, P., Tian, M., Xu, A.-D., & Ma, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s511842 · Cited by 10
“34,35 Our previous experiments demonstrated miR-141-3p orchestrates PTEN, a critical modulator of insulin resistance in hepatocytes.”
Guo, Y., Xu, N., Meng, Q., Zhong, M., Yang, M., Xu, F., Zhang, L., Jiang, M., Wu, J., Ma, Z., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119938 · Cited by 13
Matawali, A., Yeap, J. W., Sulaiman, S. F., & Tan, M. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.04.010 · Cited by 12
Xie, S., Liu, M., Kong, Y., Yang, Y., Chen, R., Wang, Y., Cao, S., & Song, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1549096 · Cited by 15
Xiong, M.-J., Cui, R., Hu, T.-G., & Wu, H.-C. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106414 · Cited by 10
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Jiao, Q., Huang, Y., He, J., & Xu, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020238 · Cited by 13
“…glucagon work together to maintain normal glucose levels in the body, where insulin binds to the insulin receptor and facilitates the translocation of the glucose transporter from intracellular vesicles to the surface of the cell membrane, thereby promoting glucose uptake and utilization [244,245].”
Qin, X., Yang, M., Yu, Y., Wang, X., Zheng, Y., Cai, R., & Pang, W. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-01137-x · Cited by 8
“For example, the AMPK [21], PI3K [22], MAPK [23, 24], JAK/STAT [25] and Wnt/β-catenin [26, 27] signaling pathways are involved in appetite regulation, metabolic homeostasis and lipid deposition.”
Ahmed, A., Cule, M., Naz, A., Thanaj, M., Sorokin, E. P., Odoemelam, C. S., Whitcher, B. J., Sattar, N. A., Bell, J. D., Thomas, E. L., et al. (2025) · Journal of Obesity · doi:10.1155/jobe/7792701 · Cited by 11
Melini, S., Pirozzi, C., Lama, A., Comella, F., Opallo, N., Piano, F. D., Napoli, E. D., Mollica, M. P., Paciello, O., Ferrante, M. C., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8361 · Cited by 9
“Our results suggest the crucial role of AKT in NORM3 effects, consistently with the involvement of AKT activation in improving insulin sensitivity, regulation of gluconeogenesis, and recovery of hepatic oxidative redox balance in diabetes and obesity (Huang et al. 2018).”
Peng, C. C., Chen, E. C. Y., Chen, C., Chyau, C.-C., Chen, K., & Peng, R. Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306575 · Cited by 7
“PI3K/AKT was suggested to regulate glucose metabolism through Forkhead box protein O1 (FoxO1) and glycogen synthase kinase 3 (GSK-3) and lipid metabolism through mammalian target of rapamycin complex 1 (mTORC1) and SREBP in obesity and T2DM [14].”
BackgroundSergi, D., Melloni, M., Passaro, A., & Neri, L. M. (2024) · Nutrients · doi:10.3390/nu16193243 · Cited by 9
“It has been shown that during IR, the metabolic pathway activated via PI3K/AKT/mTOR becomes impaired, but it is partially rescued by the compensatory hyperinsulinemia [32,64].”
BackgroundYang, S., Zhao, M., Lu, M., Feng, Y., Zhang, X., Wang, D., & Jiang, W.-W. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060333 · Cited by 10
Cilostazol Attenuates Hepatic Steatosis and Intestinal Disorders in Nonalcoholic Fatty Liver Disease
Min, T., Qiu, S., Bai, Y., Cao, H., Guo, J., & Su, Z.-Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116280 · Cited by 10
“NAFLD is often associated with obesity, diabetes, hypertension, and hyperlipidemia [2].”
BackgroundSelf-citationLiu, Y., Luo, J., & Xu, B. (2024) · Life · doi:10.3390/life14060656 · Cited by 9
Wang, L., Zhang, J., Liu, A.-Z., Pei, H., Tian, Y., Chang, Y.-Q., Hao, Z., & Ding, J. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741031 · Cited by 10
Li, Y., Wu, F., Zhang, J., Xu, Y., Chang, H., Yu, Y., Jiang, C., Gao, X., Liu, H., Chen, Z., et al. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s439876 · Cited by 11
“55 The AKT protein is a core downstream factor of insulin/PI3K/AKT signalling, 56,57 is widely expressed in insulin-sensitive tissues, and can regulate glucose metabolism by inducing downstream molecules such as Glut to enhance glucose uptake.”
BackgroundGenetic Factors Associated with the Development of Neuropathy in Type 2 Diabetes
Tordai, D. Z., Hajdú, N., Rácz, R., Istenes, I., Békeffy, M. Z., Vági, O. E., Kempler, M., Körei, A. E., Tóbiás, B., Illés, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031815 · Cited by 9
“RXRA also activates the PI3K/AKT pathway, which is known to be involved in the development of obesity and T2DM [39].”
BackgroundYuan, Z., Zhu, X., Dai, Y.-K., Shi, L., Feng, Z., Li, Z.-Y., Diao, N.-C., Guo, A., Yin, H.-Y., & Ma, L.-F. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-07149-4 · Cited by 10
“Correspondingly, PI3K/AKT pathway has been reported to be identified as therapeutic targets of obesity and T2DM [31].”
BackgroundHe, J., Fan, F., Li, J.-X., Han, Y., Song, Y., Zhang, R., Xu, Y., Wu, H., & Fan, R. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2297567 · Cited by 10
“Phosphatidylinositide 3-kinases (PI3K) is an intra-cellular phosphatidylinositol kinase, and AKT is a serine/threonine-specific protein kinase that plays a key role in various cell growth processes [19].”
BackgroundThe C5aR1 complement receptor: A novel immunomodulator of insulin action in skeletal muscle.
Shah, D., McNeilly, A., McCrimmon, R., & Hundal, H. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110944 · Cited by 10
Li, L., Gao, Y., Xu, Y., Su, D., Yang, Q., Liu, A., Wang, S., Tang, X., Zhao, J., Luo, L., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7949 · Cited by 10
Xu, M., Wang, W., Feng, J., Ruan, Z., Le, Y.-F., Liu, Y., Zhang, Q., & Wang, C. (2023) · Environment International · doi:10.1016/j.envint.2023.108088 · Cited by 10
Chae, S. A., Du, ., Son, J. S., & Zhu, M. J. (2023) · The Journal of Physiology · doi:10.1113/jp284552 · Cited by 12
“…stimulates mitochondrial biogenesis (Herzig & Shaw, 2018) and browning adipogenesis (Daval et al., 2006; Desjardins & Steinberg, 2018); and (2) APJ-dependent Gαi activation (Nakano et al., 2017) in promoting lipolysis (Choi et al., 2010; Huang et al., 2018) and cell proliferation (Yu & Cui, 2016).”
BackgroundHuang, Z.-F., Chen, J., Wang, C., Xiao, M., Zhu, Y., Li, N., Huang, Z.-R., Liu, B., & Huang, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105489 · Cited by 10
Association between lipid peroxidation biomarkers and microRNA expression profiles
Zhao, Y., Nogueira, M., Milne, G. L., Guo, X.-Y., Cai, H., Lan, Q., Rothman, N., Cai, Q., Gao, Y.-T., Chen, Q.-X., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102531 · Cited by 10
“PI3K/AKT has been associated with lipid metabolism to promote lipid biosynthesis and inhibit lipolysis, a dynamic and tightly controlled process accompanied by lipid peroxidation [44].”
BackgroundShort variation of the sheep PDGFD gene is correlated with litter size
Su, P. P., Luo, Y., Huang, Y., Akhatayeva, Z., Xin, D., Guo, Z., Pan, C., Zhang, Q., Xu, H., & Lan, X. (2022) · Gene · doi:10.1016/j.gene.2022.146797 · Cited by 10
Prakash, G., Chaudhary, A. A., Tanu, R., Ali, M. A. M., Boufahja, F., Sharma, P. K., Lakhawat, S. S., Yadav, T., Upadhyay, N. K., & Kumar, V. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010113 · Cited by 11
“Collectively, targeting AMPK, PI3K/AKT, and cAMP/PKA pathways through both pharmacological and natural therapies represents a comprehensive approach to improving insulin action and managing diabetes [38,39].”
Impact of Incretin-Based Therapy on Skeletal Muscle Health
Koceva, A., Janež, A., & Jensterle, M. (2025) · Medicina · doi:10.3390/medicina61091691 · Cited by 13
“In obesity and diabetes, skeletal muscle PI3K/Akt signaling is impaired, while PTP1B expression is elevated, contributing to insulin resistance and muscle atrophy [14–16].”
Empagliflozin alleviates type 2 diabetic renal fibrosis by inhibiting SLC7A7-mediated ferroptosis
Zhao, W., Jin, G., Sun, W., Wu, C., Yang, Q., Xue, L., & Ye, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01902-6 · Cited by 7
“It has been shown that the PI3K-AKT signaling pathway [59, 60] is associated with numerous complications of T2DM, which is consistent with our study.”
Glabridin Alleviates Metabolic Disorders in Diet‐Induced Diabetic Mice
Yang, X.-X., Lai, K.-Y., Zhang, J.-Y., Chen, Z.-Y., Ding, W., Jiang, Y., & Liu, Y. (2025) · Phytotherapy Research · doi:10.1002/ptr.8517 · Cited by 9
“In metabolic tissues like the liver and muscle, AKT coordinates the balance between lipid synthesis and oxidation (Huang et al. 2018; Ma et al. 2024).”
Naseem, S., & Rizwan, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112285 · Cited by 10
Mohebinejad, M., Kazeminasab, F., Rad, M. G., Bagheri, R., Razi, M., Willoughby, D. S., & Dutheil, F. (2025) · Nutrients · doi:10.3390/nu17091404 · Cited by 9
“The AKT3-mTOR-IGF-1 signaling pathway plays a crucial role in regulating glucose uptake in muscle cells, acting as a key mechanism for insulin sensitivity and muscle metabolism [56].”
Wang, Y., Zhang, H., Wang, X., Zhang, Y., Fan, L., Ma, Y., & Liu, X. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106442 · Cited by 2
Wang, M.-Y., Zhou, Z.-W., Wei, Y., He, R.-R., Yang, J., Zhang, X., Li, X.-Y., Zhao, D.-Q., Li, Z.-H., Leng, X.-Y., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119334 · Cited by 9
Qin, Y., Guo, J.-L., Lin, Y.-C., You, Y.-L., Huang, W.-D., & Zhan, J.-C. (2024) · Antioxidants · doi:10.3390/antiox13121490 · Cited by 9
Self-citationFER1L6 ameliorates insulin resistance by regulating GLUT4 expression
Tang, Q., Liang, Z., Yuan, J.-J., Shaaban, E., Wei, J.-F., & Liu, Z.-H. (2024) · Food & Medicine Homology · doi:10.26599/fmh.2025.9420070 · Cited by 9
Park, J. E., & Han, J.-S. (2024) · Toxicology Research · doi:10.1093/toxres/tfae197 · Cited by 8
Fang, H., Dai, L., Zhang, Z., Chen, H., Zheng, Z., Jiang, D., & Wang, W. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117160 · Cited by 11
Khan, A., Sayaf, A. M., Alshammarri, A., Zahid, M., Al‐Zoubi, R. M., Shkoor, M., Tarek, B., Wei, D., & Agouni, A. (2024) · ChemistrySelect · doi:10.1002/slct.202402379 · Cited by 9
Jamal, N. H., Hollabaugh, W. L., Scott, L., & Takkouche, S. K. (2024) · Clinical Obesity · doi:10.1111/cob.12700 · Cited by 9
Durrani, I. A., John, P., Bhatti, A., & Khan, J. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36650 · Cited by 9
“Targeting AKT and NFKB and their pathways has been pursued as therapeutic strategies for T2DM [150,178], TNBC [179,180], and OA [181,182].”
BackgroundLi, Y., He, Q., Chen, S., Dli, H., Zhao, J.-L., Sun, X., Yang, P.-Y., Mao, Q.-W., & Xia, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116412 · Cited by 9
Peng, H., Jin, M., Cui, X., Cao, H., Zhan, W., Deng, Y., Xie, S., & Zhou, Q. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741378 · Cited by 10
Gao, Y.-D., Wu, Y., Tie, F., & Wang, H.-L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32007 · Cited by 9
“The PI3K/AKT signaling pathway is necessary for normal metabolism due to its own characteristics, and its imbalance can lead to the development of obesity and T2DM [52].”
BackgroundGoyal, A., Sikarwar, O., Verma, A., Solanki, K., Agrawal, N., Dubey, N., & Yadav, H. N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23739 · Cited by 7
Zhang, M.-F., Zha, X.-T., Ma, X.-M., La, Y., Guo, X., Chu, M., Bao, P., Yan, P., Wu, X.-Y., & Liang, C.-N. (2024) · Animals · doi:10.3390/ani14050695 · Cited by 9
“The PI3K-Akt signaling pathway promotes lipid biosynthesis and inhibits lipolysis [54–56].”
BackgroundKondo, S., Adachi, S.-I., Komatsu, W., Yoshizawa, F., & Yagasaki, K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020068 · Cited by 9
“Physiologically, insulin and adiponectin activate the PI3K/Akt and AMPK pathways, respectively, resulting in GU via GLUT4 membrane translocation [37,38].”
BackgroundThottappillil, A., Sahoo, S., Chakraborty, A., Kouser, S., Ravi, V., Garawadmath, S., Banvi, P. G., Kukkupuni, S. K., Mohan, S. S., & Vishnuprasad, C. N. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2276880 · Cited by 7
“The other critical markers were insulin signalling molecules like AKT1 and PI3K, demonstrating that these core pathways involved in diabetic pathogenesis can be regulated by the multitargeted action of NK (Huang et al., 2018).”
Liu, G., Yang, L., Tang, Y.-F., Lin, J.-C., Wang, F., Shen, J., Chang, B., & Kong, X.-N. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117330 · Cited by 9
Self-citationElnageeb, M. E., Elfaki, I., Adam, M. I. E., Adam, K. M., Alameen, A. O., Elfadl, A. K., Albalawi, I. A., Almasoudi, K. S., Almotairi, R., Alsaedi, B. S. O., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090471 · Cited by 9
Liu, X., Cai, S., Yi, J., & Chu, C. (2023) · Nutrients · doi:10.3390/nu15184080 · Cited by 9
Li, M., Yao, L., He, M., Huang, H., Zheng, H., Ma, S., Zhong, Z., Yu, S., Sun, M., & Wang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185022 · Cited by 10
“When the insulin signaling pathway is abnormal, the phosphorylation expression of PI3K and AKT is significantly reduced (24).”
BackgroundCurrent and future approaches for in vitro hit discovery in diabetes mellitus
Zhang, X., Kupczyk, E., Schmitt‐Kopplin, P., & Mueller, C. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.07.016 · Cited by 13
Insulin resistance: mechanisms and therapeutic interventions
Yu, L., Qian, J., Li, X., Tian, M., Bai, X., Yang, J., Deng, R., Lu, C., He, X., Lü, A., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00408-5 · Cited by 12
“Activated Akt regulates multiple downstream effectors involved in glucose and lipid metabolism, thereby playing a central role in insulin-mediated biological processes [54].”
Dandapani, S., & Hwang, Y. (2026) · Mechanobiology · doi:10.1177/29780241261418480 · Cited by 8
Hossain, M. M., Evamoni, F. Z., & Morshed, M. M. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100117 · Cited by 8
Reytor-González, C., Cevallos-Fernández, E., Jácome, B., & Simancas-Racines, D. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1655889 · Cited by 7
“Energy-sensing by adenosine monophosphate-activated protein kinase (AMPK) complements this program by enhancing GLUT4 trafficking and fatty-acid oxidation when the adenosine monophosphate/adenosine triphosphate (AMP/ATP) ratio rises, sustaining postprandial metabolic flexibility (41, 42).”
Roney, M., & Aluwi, M. F. F. M. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01888-y · Cited by 7
“Activated Akt enhances translocation of GLUT4 to the cell surface, thereby increas - ing glucose uptake, while simultaneously suppressing hepatic glucose output, maintaining systemic glucose homeostasis [57 , 58 ].”
Wang, Z., Li, Y., Fu, W., & Wu, J. (2025) · Food Nutrition · doi:10.1016/j.fnutr.2025.100019 · Cited by 12
Nguyen, V., Dinh, Q., Fen, Y., Jia, S., & Wang, X. (2025) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-025-01136-z · Cited by 11
Rached, N. A., Dietrich, J. W., Ocker, L., Stockfleth, E., Haven, Y., Myszkowski, D., & Bechara, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072145 · Cited by 8
“An imbalance can lead to the development of obesity and type 2 diabetes mellitus [51].”
Wen, X., Zhang, X., Wang, W.-T., Zhao, F.-Q., Xie, M.-Y., Pei, G., Cao, J., El-Seedi, H. R., Ye, H., Yang, J., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142027 · Cited by 8
Zhong, Y., Xie, Y., Lyu, J., Xie, Y., Zhao, C., & Yu, J. (2025) · Food Research International · doi:10.1016/j.foodres.2025.115759 · Cited by 9
Pang, J., Huang, X., Gao, Y., Guan, X., Xiong, L., Li, L., Yin, N., Dai, M., Han, T., & Yi, W. (2025) · Scientific Reports · doi:10.1038/s41598-024-83714-8 · Cited by 8
Self-citationFerko, M., Alánová, P., Janko, D., Opletalová, B., & Andelová, N. (2024) · Physiological Research · doi:10.33549/physiolres.935513 · Cited by 7
Metadata
- Authors
- Huang, X., Liu, G., Guo, J., & Su, Z.
- Affiliations
- Guangdong Pharmaceutical University (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
- Corresponding author
- Guo, Jiao
- Su, Zhengquan
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 14
- Issue
- 11
- Pages
- 1483-1496
- ISSN
- 1449-2288 (ISSN-L)
- PMC
- PMC6158718
- OpenAlex
- W2886504687
- Cited by
- 1,673
- References
- 171
- Citations by year
- 2026: 197 · 2025: 296 · 2024: 282 · 2023: 258 · 2022: 246 · 2021: 211 · 2020: 136 · 2019: 44 · 2018: 3
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- International Journal of Biological Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (2017-02, 81173107)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- PI3K/Akt signaling, obesity, type 2 diabetes, insulin resistance, hyperglycemia, skeletal muscle, adipose tissue, liver, pancreas, therapeutic target, metabolic disorders
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review